|
|
||||||||
Physiological Reviews, Vol 63, 1420-1480, Copyright © 1983 by American Physiological Society
JOURNAL ARTICLE |
J. Bremer
Carnitine was detected at the beginning of this century, but it was nearly forgotten among biochemists until its importance in fatty acid metabolism was established 50 years later. In the last 30 years, interest in the metabolism and functions of carnitine has steadily increased. Carnitine is synthesized in most eucaryotic organisms, although a few insects (and most likely some newborn animals) require it as a nutritional factor (vitamin BT). Carnitine biosynthesis is initiated by methylation of lysine. The trimethyllysine formed is subsequently converted to butyrobetaine in all tissues; the butyrobetaine is finally hydroxylated to carnitine in the liver and, in some animals, in the kidneys (see Fig. 1). It is released from these tissues and is then actively taken up by all other tissues. The turnover of carnitine in the body is slow, and the regulation of its synthesis is still incompletely understood. Microorganisms (e.g., in the intestine) can metabolize carnitine to trimethylamine, dehydrocarnitine (beta-keto-gamma-trimethylaminobutyric acid), betaine, and possibly to trimethylaminoacetone. In some insects carnitine can be converted to methylcholine, presumably with trimethylaminoacetone as an intermediate (see Fig. 3). In mammals the unphysiological isomer (+) carnitine is converted to trimethylaminoacetone. The natural isomer (-)carnitine is excreted unchanged in the urine, and it is still uncertain if it is degraded in mammalian tissues at all (Fig. 2). The only firmly established function of carnitine is its function as a carrier of activated fatty acids and activated acetate across the inner mitochondrial membrane. Two acyl-CoA:carnitine acyltransferases with overlapping chain-length specificities have been isolated: one acetyltransferase taking part in the transport of acetyl and short-chain acyl groups and one palmitoyltransferase taking part in the transport of long-chain acyl groups. An additional octanoyltransferase has been isolated from liver peroxisomes. Although a carnitine translocase that allows carnitine and acylcarnitine to penetrate the inner mitochondrial membrane has been deduced from functional studies (see Fig. 5), this translocase has not been isolated as a protein separate from the acyltransferases. Carnitine acetyltransferase and carnitine octanoyltransferase are also found in the peroxisomes. In these organelles the enzymes may be important in the transfer of acyl groups, which are produced by the peroxisomal beta-oxidation enzymes, to the mitochondria for oxidation in the citric acid cycle. The carnitine-dependent transport of activated fatty acids across the mitochondrial membrane is a regulated process. Malonyl-CoA inh
This article has been cited by other articles:
![]() |
L. Xi, K. Brown, J. Woodworth, K. Shim, B. Johnson, and J. Odle Maternal Dietary L-Carnitine Supplementation Influences Fetal Carnitine Status and Stimulates Carnitine Palmitoyltransferase and Pyruvate Dehydrogenase Complex Activities in Swine J. Nutr., December 1, 2008; 138(12): 2356 - 2362. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Birkenfeld, P. Budziarek, M. Boschmann, C. Moro, F. Adams, G. Franke, M. Berlan, M. A. Marques, F. C.G.J. Sweep, F. C. Luft, et al. Atrial Natriuretic Peptide Induces Postprandial Lipid Oxidation in Humans Diabetes, December 1, 2008; 57(12): 3199 - 3204. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Garrett, S. Xu, P. A. Simmons, J. Vehige, J. L. Flanagan, and M. D. Willcox Expression and Localization of Carnitine/Organic Cation Transporter OCTN1 and OCTN2 in Ocular Epithelium Invest. Ophthalmol. Vis. Sci., November 1, 2008; 49(11): 4844 - 4849. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E Reuter, A. M Evans, D. H Chace, and G. Fornasini Determination of the reference range of endogenous plasma carnitines in healthy adults Ann Clin Biochem, November 1, 2008; 45(6): 585 - 592. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D Evans, T. F Jacobs, and E. W Evans Role of Acetyl-L-Carnitine in the Treatment of Diabetic Peripheral Neuropathy Ann. Pharmacother., November 1, 2008; 42(11): 1686 - 1691. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Fenkci, V. Fenkci, O. Oztekin, S. Rota, and N. Karagenc Serum total L-carnitine levels in non-obese women with polycystic ovary syndrome Hum. Reprod., July 1, 2008; 23(7): 1602 - 1606. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Zhai, S. L. Neuman, M. A. Latour, and P. Y. Hester The Effect of Male and Female Supplementation of L-Carnitine on Reproductive Traits of White Leghorns Poult. Sci., June 1, 2008; 87(6): 1171 - 1181. [Abstract] [Full Text] [PDF] |
||||
![]() |
T Tsakiris, P Angelogianni, C Tesseromatis, S Tsakiris, and K H Schulpis Effect of L-carnitine administration on the modulated rat brain protein concentration, acetylcholinesterase, Na+K+-ATPase and Mg2+-ATPase activities induced by forced swimming Br. J. Sports Med., May 1, 2008; 42(5): 367 - 372. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Zhai, S. L. Neuman, M. A. Latour, and P. Y. Hester The Effect of Dietary L-Carnitine on Semen Traits of White Leghorns Poult. Sci., October 1, 2007; 86(10): 2228 - 2235. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Makino, T. Sugiura, T. Ito, N. Sugiyama, and N. Koyama Carnitine-Associated Encephalopathy Caused by Long-term Treatment With an Antibiotic Containing Pivalic Acid Pediatrics, September 1, 2007; 120(3): e739 - e741. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Takahashi, T. Asai, H. Murakami, R. Murakami, M. Tsuzuki, Y. Numaguchi, H. Matsui, T. Murohara, and K. Okumura Pressure Overload-Induced Cardiomyopathy in Heterozygous Carrier Mice of Carnitine Transporter Gene Mutation Hypertension, September 1, 2007; 50(3): 497 - 502. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Urban, R. C. Gallagher, C. Brown, R. A. Castro, L. L. Lagpacan, C. M. Brett, T. R. Taylor, E. J. Carlson, T. E. Ferrin, E. G. Burchard, et al. Functional Genetic Diversity in the High-Affinity Carnitine Transporter OCTN2 (SLC22A5) Mol. Pharmacol., November 1, 2006; 70(5): 1602 - 1611. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Bain, R. W. Milne, and A. M. Evans Disposition and Metabolite Kinetics of Oral L-carnitine in Humans. J. Clin. Pharmacol., October 1, 2006; 46(10): 1163 - 1170. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Asai, K. Okumura, R. Takahashi, H. Matsui, Y. Numaguchi, H. Murakami, R. Murakami, and T. Murohara Combined therapy with PPAR{alpha} agonist and L-carnitine rescues lipotoxic cardiomyopathy due to systemic carnitine deficiency Cardiovasc Res, June 1, 2006; 70(3): 566 - 577. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Kobayashi, M. Irokawa, T. Maeda, A. Tsuji, and I. Tamai Carnitine/organic cation transporter OCTN2-mediated transport of carnitine in primary-cultured epididymal epithelial cells Reproduction, December 1, 2005; 130(6): 931 - 937. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Takahashi, K. Okumura, T. Asai, T. Hirai, H. Murakami, R. Murakami, Y. Numaguchi, H. Matsui, M. Ito, and T. Murohara Dietary fish oil attenuates cardiac hypertrophy in lipotoxic cardiomyopathy due to systemic carnitine deficiency Cardiovasc Res, November 1, 2005; 68(2): 213 - 223. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mancinelli, A. M. Evans, R. L. Nation, and A. Longo Uptake of L-Carnitine and Its Short-Chain Ester Propionyl-L-carnitine in the Isolated Perfused Rat Liver J. Pharmacol. Exp. Ther., October 1, 2005; 315(1): 118 - 124. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Michno, A. Raszeja-Specht, A. Jankowska-Kulawy, T. Pawelczyk, and A. Szutowicz Effect of L-Carnitine on Acetyl-CoA Content and Activity of Blood Platelets in Healthy and Diabetic Persons Clin. Chem., September 1, 2005; 51(9): 1673 - 1682. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Kobayashi, A. Goto, T. Maeda, J.-i. Nezu, A. Tsuji, and I. Tamai OCTN2-mediated transport of carnitine in isolated Sertoli cells Reproduction, June 1, 2005; 129(6): 729 - 736. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Grube, H. M. z. Schwabedissen, K. Draber, D. Prager, K.-U. Moritz, K. Linnemann, C. Fusch, G. Jedlitschky, and H. K. Kroemer EXPRESSION, LOCALIZATION, AND FUNCTION OF THE CARNITINE TRANSPORTER OCTN2 (SLC22A5) IN HUMAN PLACENTA Drug Metab. Dispos., January 1, 2005; 33(1): 31 - 37. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kobayashi, N. Ohshiro, A. Tsuchiya, N. Kohyama, M. Ohbayashi, and T. Yamamoto RENAL TRANSPORT OF ORGANIC COMPOUNDS MEDIATED BY MOUSE ORGANIC ANION TRANSPORTER 3 (MOAT3): FURTHER SUBSTRATE SPECIFICITY OF MOAT3 Drug Metab. Dispos., May 1, 2004; 32(5): 479 - 483. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Gilbert-Barness Metabolic Cardiomyopathy and Conduction System Defects in Children Ann. Clin. Lab. Sci., January 1, 2004; 34(1): 15 - 34. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Pisano, G. Pratesi, D. Laccabue, F. Zunino, P. Lo Giudice, A. Bellucci, L. Pacifici, B. Camerini, L. Vesci, M. Castorina, et al. Paclitaxel and Cisplatin-Induced Neurotoxicity: A Protective Role of Acetyl-L-Carnitine Clin. Cancer Res., November 15, 2003; 9(15): 5756 - 5767. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Bykov, H. Jarvelainen, and K. Lindros L-CARNITINE ALLEVIATES ALCOHOL-INDUCED LIVER DAMAGE IN RATS: ROLE OF TUMOUR NECROSIS FACTOR-ALPHA Alcohol Alcohol., September 1, 2003; 38(5): 400 - 406. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Takahashi, K. Okumura, H. Matsui, Y. Saburi, H. Kamiya, K. Matsubara, T. Asai, M. Ito, and T. Murohara Impact of {alpha}-tocopherol on cardiac hypertrophy due to energy metabolism disorder: the involvement of 1,2-diacylglycerol Cardiovasc Res, June 1, 2003; 58(3): 565 - 574. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Berge, K. J. Tronstad, P. Bohov, L. Madsen, and R. K. Berge Impact of mitochondrial {beta}-oxidation in fatty acid-mediated inhibition of glioma cell proliferation J. Lipid Res., January 1, 2003; 44(1): 118 - 127. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Spaniol, P. Kaufmann, K. Beier, J. Wuthrich, M. Torok, H. Scharnagl, W. Marz, and S. Krahenbuhl Mechanisms of liver steatosis in rats with systemic carnitine deficiency due to treatment with trimethylhydraziniumpropionate J. Lipid Res., January 1, 2003; 44(1): 144 - 153. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Kopple, H. Ding, A. Letoha, B. Ivanyi, D. P.-Y. Qing, L. Dux, H.-Y. Wang, and S. Sonkodi L-carnitine ameliorates gentamicin-induced renal injury in rats Nephrol. Dial. Transplant., December 1, 2002; 17(12): 2122 - 2131. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. P. Brass Pivalate-Generating Prodrugs and Carnitine Homeostasis in Man Pharmacol. Rev., December 1, 2002; 54(4): 589 - 598. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Jung, M. Buchholz, J. Clausen, M. Nietschke, A. Revermann, R. Schmid, and K. Jung CaiT of Escherichia coli, a New Transporter Catalyzing L-Carnitine/gamma -Butyrobetaine Exchange J. Biol. Chem., October 11, 2002; 277(42): 39251 - 39258. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Enomoto, M. F. Wempe, H. Tsuchida, H. J. Shin, S. H. Cha, N. Anzai, A. Goto, A. Sakamoto, T. Niwa, Y. Kanai, et al. Molecular Identification of a Novel Carnitine Transporter Specific to Human Testis. INSIGHTS INTO THE MECHANISM OF CARNITINE RECOGNITION J. Biol. Chem., September 20, 2002; 277(39): 36262 - 36271. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Rodriguez, J. C. Labus, and B. T. Hinton Organic Cation/Carnitine Transporter, OCTN2, Is Differentially Expressed in the Adult Rat Epididymis Biol Reprod, July 1, 2002; 67(1): 314 - 319. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. M. Vaz, B. Melegh, J. Bene, D. Cuebas, D. A. Gage, A. Bootsma, P. Vreken, A. H. van Gennip, L. L. Bieber, and R. J.A. Wanders Analysis of Carnitine Biosynthesis Metabolites in Urine by HPLC-Electrospray Tandem Mass Spectrometry Clin. Chem., June 1, 2002; 48(6): 826 - 834. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Y. Kong and S. W. Rabkin Palmitate-induced cardiac apoptosis is mediated through CPT-1 but not influenced by glucose and insulin Am J Physiol Heart Circ Physiol, February 1, 2002; 282(2): H717 - H725. [Abstract] [Full Text] [PDF] |
||||
![]() |
R Lango, R.T Smolenski, M Narkiewicz, J Suchorzewska, and W Lysiak-Szydlowska Influence of L-carnitine and its derivatives on myocardial metabolism and function in ischemic heart disease and during cardiopulmonary bypass Cardiovasc Res, July 1, 2001; 51(1): 21 - 29. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mancinelli, A. Longo, R. L. Nation, and A. M. Evans Disposition of L-Carnitine and Its Short-Chain Esters, Acetyl-L-carnitine and Propionyl-L-carnitine, in the Rat Isolated Perfused Liver Drug Metab. Dispos., April 13, 2001; 28(12): 1401 - 1404. [Full Text] |
||||
![]() |
S. L. Kennedy, W. C. Stanley, A. R. Panchal, and R. S. Mazzeo Alterations in enzymes involved in fat metabolism after acute and chronic altitude exposure J Appl Physiol, January 1, 2001; 90(1): 17 - 22. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. P Brass Supplemental carnitine and exercise Am. J. Clinical Nutrition, August 1, 2000; 72(2): 618S - 623. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. M. Vaz, S. W. Fouchier, R. Ofman, M. Sommer, and R. J. A. Wanders Molecular and Biochemical Characterization of Rat gamma -Trimethylaminobutyraldehyde Dehydrogenase and Evidence for the Involvement of Human Aldehyde Dehydrogenase 9 in Carnitine Biosynthesis J. Biol. Chem., March 15, 2000; 275(10): 7390 - 7394. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ohashi, I. Tamai, H. Yabuuchi, J.-I. Nezu, A. Oku, Y. Sai, M. Shimane, and A. Tsuji Na+-Dependent Carnitine Transport by Organic Cation Transporter (OCTN2): Its Pharmacological and Toxicological Relevance J. Pharmacol. Exp. Ther., November 1, 1999; 291(2): 778 - 784. [Abstract] [Full Text] |
||||
![]() |
N. ANDRIEU-ABADIE, J.-P. JAFFRÉZOU, S. HATEM, G. LAURENT, T. LEVADE, and J.-J. MERCADIER L-carnitine prevents doxorubicin-induced apoptosis of cardiac myocytes: role of inhibition of ceramide generation FASEB J, September 1, 1999; 13(12): 1501 - 1510. [Abstract] [Full Text] |
||||
![]() |
H. Nakajima, F. Inoue, Z. Kizaki, N. Terada, M. Okochi, A. Kinugasa, and T. Sawada Carnitine Import to Isolated Hepatocytes and Synthesis Are Accelerated in Pivalate-Treated Rats J. Nutr., September 1, 1999; 129(9): 1688 - 1691. [Abstract] [Full Text] |
||||
![]() |
T. M. Visarius, J. W. Stucki, and B. H. Lauterburg Inhibition and Stimulation of Long-Chain Fatty Acid Oxidation by Chloroacetaldehyde and Methylene Blue in Rats J. Pharmacol. Exp. Ther., May 1, 1999; 289(2): 820 - 824. [Abstract] [Full Text] |
||||
![]() |
M. Kuwajima, H. Harashima, M. Hayashi, S. Ise, M. Sei, K.-m. Lu, H. Kiwada, Y. Sugiyama, and K. Shima Pharmacokinetic Analysis of the Cardioprotective Effect of 3-(2,2,2-Trimethylhydrazinium) Propionate in Mice: Inhibition of Carnitine Transport in Kidney J. Pharmacol. Exp. Ther., April 1, 1999; 289(1): 93 - 102. [Abstract] [Full Text] |
||||
![]() |
V. Srikanth, T. Malini, J. Arunakaran, P. Govindarajulu, and K. Balasubramanian Effects of Ethanol Treatment on Epididymal Secretory Products and Sperm Maturation in Albino Rats J. Pharmacol. Exp. Ther., February 1, 1999; 288(2): 509 - 515. [Abstract] [Full Text] |
||||
![]() |
J. Nakamura, N. Koh, F. Sakakibara, Y. Hamada, T. Hara, H. Sasaki, S. Chaya, T. Komori, E. Nakashima, K. Naruse, et al. Polyol Pathway Hyperactivity Is Closely Related to Carnitine Deficiency in the Pathogenesis of Diabetic Neuropathy of Streptozotocin-Diabetic Rats J. Pharmacol. Exp. Ther., December 1, 1998; 287(3): 897 - 902. [Abstract] [Full Text] |
||||
![]() |
I. Tamai, R. Ohashi, J.-i. Nezu, H. Yabuuchi, A. Oku, M. Shimane, Y. Sai, and A. Tsuji Molecular and Functional Identification of Sodium Ion-dependent, High Affinity Human Carnitine Transporter OCTN2 J. Biol. Chem., August 7, 1998; 273(32): 20378 - 20382. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Berthon, R. A. Howlett, G. J. F. Heigenhauser, and L. L. Spriet Human skeletal muscle carnitine palmitoyltransferase I activity determined in isolated intact mitochondria J Appl Physiol, July 1, 1998; 85(1): 148 - 153. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. P. Brass and W. R. Hiatt The Role of Carnitine and Carnitine Supplementation During Exercise in Man and in Individuals with Special Needs J. Am. Coll. Nutr., June 1, 1998; 17(3): 207 - 215. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hirose, A. Mitsudome, S. Yasumoto, A. Ogawa, Y. Muta, and Y. Tomoda Valproate Therapy Does Not Deplete Carnitine Levels in Otherwise Healthy Children Pediatrics, May 1, 1998; 101 (5): e9 - e9. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Rashed, M. P. Bucknall, D. Little, A. Awad, M. Jacob, M. Alamoudi, M. Alwattar, and P. T. Ozand Screening blood spots for inborn errors of metabolism by electrospray tandem mass spectrometry with a microplate batch process and a computer algorithm for automated flagging of abnormal profiles Clin. Chem., July 1, 1997; 43(7): 1129 - 1141. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Evans, A. Mancinelli, and A. Longo J. Pharmacol. Exp. Ther., June 1, 1997; 281(3): 1071 - 1076. [Abstract] [Full Text] |
||||
![]() |
V. Steffen, M. Santiago, C. de la Cruz, E. Revilla, A. Machado, and J. Cano Effect of intraventricular injection of 1-methyl-4-phenylpyridinium: protection by acetyl-L-carnitine Human and Experimental Toxicology, November 1, 1995; 14(11): 865 - 871. [Abstract] [PDF] |
||||
![]() |
R. Pons and D. C. De Vivo Primary and Secondary Carnitine Deficiency Syndromes J Child Neurol, November 1, 1995; 10(2_suppl): 2S8 - 2S24. [Abstract] [PDF] |
||||
![]() |
D. L. Coulter Carnitine Deficiency in Epilepsy: Risk Factors and Treatment J Child Neurol, November 1, 1995; 10(2_suppl): 2S32 - 2S39. [Abstract] [PDF] |
||||
![]() |
S. Winter, K. Jue, J. Prochazka, P. Francis, W. Hamilton, L. Linn, and E. Helton The Role of L-Carnitine in Pediatric Cardiomyopathy J Child Neurol, November 1, 1995; 10(2_suppl): 2S45 - 2S51. [Abstract] [PDF] |
||||
![]() |
S. L. Bratton, A. L. Garden, T. P. Bohan, J. W. French, and W. R. Clarke A Child With Valproic Acid-Associated Carnitine Deficiency and Carnitine-Responsive Cardiac Dysfunction J Child Neurol, October 1, 1992; 7(4): 413 - 416. [Abstract] [PDF] |
||||
![]() |
M. Sunamori, T. Nakagawa, S. Fujisawa, and A. Suzuki Myocardial Response to Pretreatment with L-Carnitine in Patients with Cardiac Valve Replacement Vascular and Endovascular Surgery, October 1, 1991; 25(8): 607 - 617. [Abstract] [PDF] |
||||
![]() |
D. L. Coulter Review Article: Carnitine, Valproate, and Toxicity J Child Neurol, January 1, 1991; 6(1): 7 - 14. [Abstract] [PDF] |
||||
![]() |
G. Brevetti, T. Attisano, S. Perna, A. Rossini, A. Policicchio, and M. Corsi Effect of L-Carnitine on the Reactive Hyperemia in Patients Affected by Peripheral Vascular Disease: A Double-Blind, Crossover Study Angiology, October 1, 1989; 40(10): 857 - 862. [Abstract] [PDF] |
||||
![]() |
I. Tamai, R. Ohashi, J.-i. Nezu, Y. Sai, D. Kobayashi, A. Oku, M. Shimane, and A. Tsuji Molecular and Functional Characterization of Organic Cation/Carnitine Transporter Family in Mice J. Biol. Chem., December 15, 2000; 275(51): 40064 - 40072. [Abstract] [Full Text] [PDF] |
||||